Skip to main content
Top
Published in: BMC Public Health 1/2020

Open Access 01-12-2020 | Human Immunodeficiency Virus | Research article

Burden and changes in HIV/AIDS morbidity and mortality in Southern Africa Development Community Countries, 1990–2017

Authors: Philimon N. Gona, Clara M. Gona, Suha Ballout, Sowmya R. Rao, Ruth Kimokoti, Chabila C. Mapoma, Ali H. Mokdad

Published in: BMC Public Health | Issue 1/2020

Login to get access

Abstract

Background

The 16 Southern Africa Development Community (SADC) countries remain the epicentre of the HIV/AIDS epidemic with the largest number of people living with HIV/AIDS. Anti-retroviral treatment (ART) has improved survival and prevention of mother-to-child transmission (PMTCT) of HIV, but the disease remains a serious cause of mortality. We conducted a descriptive epidemiological analysis of HIV/AIDS burden for the 16 SADC countries using secondary data from the Global Burden of Diseases, Injuries and Risk Factor (GBD) Study.

Methods

The GBD study is a systematic, scientific effort by the Institute for Health Metrics and Evaluation (IHME) to quantify the comparative magnitude of health loss due to diseases, injuries, and risk factors by age, sex, and geographies for specific points in time. We analyzed the following outcomes: mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) due to HIV/AIDS for SADC. Input data for GBD was extracted from censuses, household surveys, civil registration and vital statistics, disease registries, health service utilisation, disease notifications, and other sources. Country- and cause-specific HIV/AIDS-related death rates were calculated using the Cause of Death Ensemble model (CODEm) and spatiotemporal Gaussian process regression (ST-GPR). Deaths were multiplied by standard life expectancy at each age-group to calculate YLLs. Cause-specific mortality was estimated using a Bayesian meta-regression modelling tool, DisMod-MR. Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases to calculate YLDs. Crude and age-adjusted rates per 100,000 population and changes between 1990 and 2017 were determined for each country.

Results

In 2017, HIV/AIDS caused 336,175 deaths overall in SADC countries, and more than 20 million DALYs. This corresponds to a 3-fold increase from 113,631 deaths (6,915,170 DALYs) in 1990. The five leading countries with the proportion of deaths attributable to HIV/AIDS in 2017 were Botswana at the top with 28.7% (95% UI; 23.7–35.2), followed by South Africa 28.5% (25.8–31.6), Lesotho, 25.1% (21.2–30.4), eSwatini 24.8% (21.3–28.6), and Mozambique 24.2% (20.6–29.3). The five countries had relative attributable deaths that were at least 14 times greater than the global burden of 1.7% (1.6–1.8). Similar patterns were observed with YLDs, YLLs, and DALYs. Comoros, Seychelles and Mauritius were on the lower end, with attributable proportions less than 1%, below the global proportion.

Conclusions

Great progress in reducing HIV/AIDS burden has been achieved since the peak but more needs to be done. The post-2005 decline is attributed to PMTCT of HIV, resources provided through the US President’s Emergency Plan For AIDS Relief (PEPFAR), and behavioural change. The five countries with the highest burden of HIV/AIDS as measured by proportion of death attributed to HIV/AIDS and age-standardized mortaility rate were Botswana, South Africa, Lesotho, eSwatini, and Mozambique. SADC countries should cooperate, work with donors, and embrace the UN Fast-Track approach, which calls for frontloading investment from domestic or other sources to prevent and treat HIV/AIDS. Robust tracking, testing, and early treatment are required, as well as refinement of individual treatment strategies for transient individuals in the region.
Literature
2.
go back to reference Bucagu M, Muganda J. Implementing primary healthcare-based PMTCT interventions: operational perspectives from Muhima cohort analysis (Rwanda). Pan Afr Med J. 2014;18:59..CrossRef Bucagu M, Muganda J. Implementing primary healthcare-based PMTCT interventions: operational perspectives from Muhima cohort analysis (Rwanda). Pan Afr Med J. 2014;18:59..CrossRef
3.
go back to reference Injury Incidence and Prevalence Collaborators (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017GBD 2017 Disease. Lancet. 2018;392:1736–88..CrossRef Injury Incidence and Prevalence Collaborators (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017GBD 2017 Disease. Lancet. 2018;392:1736–88..CrossRef
4.
go back to reference GBD 2017 Disease and Injury Incidence and prevalence collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858..CrossRef GBD 2017 Disease and Injury Incidence and prevalence collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858..CrossRef
5.
go back to reference GBD 2017 DALYs and HALE collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1859–192..CrossRef GBD 2017 DALYs and HALE collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1859–192..CrossRef
6.
go back to reference GBD HIV Collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV. 2019;6(12):e831–59 UNAIDS Global HIV & AIDS..CrossRef GBD HIV Collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV. 2019;6(12):e831–59 UNAIDS Global HIV & AIDS..CrossRef
8.
go back to reference GBD 2017 Cause of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–88..CrossRef GBD 2017 Cause of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–88..CrossRef
10.
go back to reference Stevens GA, Alkema L, Black RE, Boerma JT, Collins GS, Ezzati M, Grove JT, Hogan DR, Hogan MC, Horton R, Lawn JE, Marušić A, Mathers CD, Murray CJ, Rudan I, Salomon JA, Simpson PJ, Vos T, Welch V; (The GATHER Working Group). Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet 2016;388(10062):e19-e23..CrossRef Stevens GA, Alkema L, Black RE, Boerma JT, Collins GS, Ezzati M, Grove JT, Hogan DR, Hogan MC, Horton R, Lawn JE, Marušić A, Mathers CD, Murray CJ, Rudan I, Salomon JA, Simpson PJ, Vos T, Welch V; (The GATHER Working Group). Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet 2016;388(10062):e19-e23..CrossRef
12.
go back to reference Bendavid E, Holmes CB, Bhattacharya J, Miller G. HIV development assistance and adult mortality in Africa. JAMA. 2012;307:2060–7..CrossRef Bendavid E, Holmes CB, Bhattacharya J, Miller G. HIV development assistance and adult mortality in Africa. JAMA. 2012;307:2060–7..CrossRef
13.
go back to reference Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2017 (GBD 2017) Disability Weights. Seattle: Institute for Health Metrics and Evaluation (IHME); 2018.. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2017 (GBD 2017) Disability Weights. Seattle: Institute for Health Metrics and Evaluation (IHME); 2018..
14.
go back to reference Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S, Havelaar AH, Cassini A, Devleesschauwer B, Kretzschmar M, Speybroeck N, Murray CJ, Vos T. Disability weights for the global burden of disease 2013 study. Lancet Glob Health. 2015;3:e712–23..CrossRef Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S, Havelaar AH, Cassini A, Devleesschauwer B, Kretzschmar M, Speybroeck N, Murray CJ, Vos T. Disability weights for the global burden of disease 2013 study. Lancet Glob Health. 2015;3:e712–23..CrossRef
15.
go back to reference Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Editors. Global burden of disease and risk factors. Washington (DC): the International Bank for Reconstruction and Development /the World Bank. New York: Oxford University Press; 2006..CrossRef Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Editors. Global burden of disease and risk factors. Washington (DC): the International Bank for Reconstruction and Development /the World Bank. New York: Oxford University Press; 2006..CrossRef
16.
go back to reference GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1684–735..CrossRef GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1684–735..CrossRef
17.
go back to reference Flaxman AD, Vos T, Murray CJ. An integrative meta-regression framework for descriptive epidemiology. Seattle: University of Washington Press; 2015.. Flaxman AD, Vos T, Murray CJ. An integrative meta-regression framework for descriptive epidemiology. Seattle: University of Washington Press; 2015..
18.
go back to reference UNAIDS Reference Group on Estimates Modelling and Projections. Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections; 2002. p. 16.. UNAIDS Reference Group on Estimates Modelling and Projections. Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections; 2002. p. 16..
19.
go back to reference Mahy M, Brown T, Stover J, Walker N, Stanecki K, Kirungi W, Garcia-Calleja T, Ghys PD. Producing HIV estimates: from global advocacy to country planning and impact measurement, Global Health Action; 2017.. Mahy M, Brown T, Stover J, Walker N, Stanecki K, Kirungi W, Garcia-Calleja T, Ghys PD. Producing HIV estimates: from global advocacy to country planning and impact measurement, Global Health Action; 2017..
20.
go back to reference Amanzi P, Michelo C, Simoonga C, Dambe R, Chongwe G. Survival of people on antiretroviral treatment in Zambia: a retrospective cohort analysis of HIV clients on ART. Pan Afr Med J. 2016;15(24):144.. Amanzi P, Michelo C, Simoonga C, Dambe R, Chongwe G. Survival of people on antiretroviral treatment in Zambia: a retrospective cohort analysis of HIV clients on ART. Pan Afr Med J. 2016;15(24):144..
22.
go back to reference Murray CJL, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384:1005–70..CrossRef Murray CJL, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384:1005–70..CrossRef
26.
go back to reference Stover J, Bollinger L, Izazola JA, et al. What is required to end the AIDS epidemic as a public health threat by 2030? The Cost and Impact of the Fast-Track Approach. PLoS One. 2016;11:e0154893..CrossRef Stover J, Bollinger L, Izazola JA, et al. What is required to end the AIDS epidemic as a public health threat by 2030? The Cost and Impact of the Fast-Track Approach. PLoS One. 2016;11:e0154893..CrossRef
27.
go back to reference Chin RJ, Sangmanee D, Piergallini L. PEPFAR funding and reduction in HIV infection rates in 12 focus sub-Saharan African countries: a quantitative analysis. Int J MCH AIDS. 2015;3:150–8..PubMedPubMedCentral Chin RJ, Sangmanee D, Piergallini L. PEPFAR funding and reduction in HIV infection rates in 12 focus sub-Saharan African countries: a quantitative analysis. Int J MCH AIDS. 2015;3:150–8..PubMedPubMedCentral
28.
go back to reference Renju J, Moshabela M, McLean E, et al. ‘Side effects’ are ‘central effects’ that challenge retention in HIV treatment programs in six sub-Saharan African countries: a multicountry qualitative study. Sex Transm Infect. 2017;93(Suppl 3):e052971..CrossRef Renju J, Moshabela M, McLean E, et al. ‘Side effects’ are ‘central effects’ that challenge retention in HIV treatment programs in six sub-Saharan African countries: a multicountry qualitative study. Sex Transm Infect. 2017;93(Suppl 3):e052971..CrossRef
29.
go back to reference Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J. 2011;365:493–505..CrossRef Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J. 2011;365:493–505..CrossRef
30.
go back to reference Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of HIV transmission in sero-different couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316:171–81..CrossRef Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of HIV transmission in sero-different couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316:171–81..CrossRef
31.
go back to reference Grulich AE, Bavinton BR, Jin F, et al. HIV Transmission in Male Sero-discordant Couples in Australia, Thailand and Brazil. Seattle: 2015 Conference on retroviruses and opportunistic infections (CROI); 2015.. Grulich AE, Bavinton BR, Jin F, et al. HIV Transmission in Male Sero-discordant Couples in Australia, Thailand and Brazil. Seattle: 2015 Conference on retroviruses and opportunistic infections (CROI); 2015..
32.
go back to reference Institute for Health Metrics and Evaluation. Financing Global Health 2017: funding universal health coverage and the unfinished HIV/AIDS agenda. Seattle: Institute for Health Metrics and Evaluation; 2018.. Institute for Health Metrics and Evaluation. Financing Global Health 2017: funding universal health coverage and the unfinished HIV/AIDS agenda. Seattle: Institute for Health Metrics and Evaluation; 2018..
33.
go back to reference 2015 Healthcare Access and Quality Collaborators. Health Access and Quality based o mortality from causes amenable to personal healthcare in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. Lancet. 2017;390:231–66..CrossRef 2015 Healthcare Access and Quality Collaborators. Health Access and Quality based o mortality from causes amenable to personal healthcare in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. Lancet. 2017;390:231–66..CrossRef
34.
go back to reference Gona CM, McGee E, DeMarco R. “What will become of me if they take this away?” Zimbabwean Women’s perceptions of “free” ART. J Assoc Nurses AIDS Care. 2016;27:667–76..CrossRef Gona CM, McGee E, DeMarco R. “What will become of me if they take this away?” Zimbabwean Women’s perceptions of “free” ART. J Assoc Nurses AIDS Care. 2016;27:667–76..CrossRef
39.
go back to reference Gliddon HD, Peeling RW, Kamb ML, Toskin I, Wi TE, Taylor MM. A systematic review and meta-analysis of studies evaluating the performance and operational characteristics of dual point-of-care tests for HIV and syphilis. Sex Transm Infect. 2017;93:S3–S15..CrossRef Gliddon HD, Peeling RW, Kamb ML, Toskin I, Wi TE, Taylor MM. A systematic review and meta-analysis of studies evaluating the performance and operational characteristics of dual point-of-care tests for HIV and syphilis. Sex Transm Infect. 2017;93:S3–S15..CrossRef
41.
go back to reference Oliva-Moreno J, Trapero-Bertran M. Economic impact of HIV in the highly active antiretroviral therapy era – reflections looking forward. AIDS Rev. 2018;20:226–35..PubMed Oliva-Moreno J, Trapero-Bertran M. Economic impact of HIV in the highly active antiretroviral therapy era – reflections looking forward. AIDS Rev. 2018;20:226–35..PubMed
Metadata
Title
Burden and changes in HIV/AIDS morbidity and mortality in Southern Africa Development Community Countries, 1990–2017
Authors
Philimon N. Gona
Clara M. Gona
Suha Ballout
Sowmya R. Rao
Ruth Kimokoti
Chabila C. Mapoma
Ali H. Mokdad
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2020
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-020-08988-9

Other articles of this Issue 1/2020

BMC Public Health 1/2020 Go to the issue